HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lauder appointment

This article was originally published in The Rose Sheet

Executive Summary

Clinique North American President Eunice Valdivia will leave current post to work on Lauder's specialty brands, firm announces Dec. 18. Valdivia's new title has yet to be announced, but exec will report to Group President Daniel Brestle in her new capacity, effective Jan. 1. No one will be appointed to succeed Valdivia at Clinique; instead, her duties will be divided among brand's existing staff. Exec has been with Clinique since 1969, and has served as president of brand's North American division since January 2003 (1"The Rose Sheet" Dec. 16, 2003, p. 6)...

You may also be interested in...



Estee Lauder Promotes Greene To Clinique Worldwide President

Estee Lauder has tapped Specialty Group Worldwide President Lynne Greene to head Clinique Worldwide, effective Jan. 1, the company announced Dec. 2. She will report to Group President Philip Shearer

Estee Lauder, Clinique Appoint North American Presidents

Estee Lauder has appointed Janet Cook North American president for the Estee Lauder brand, and Eunice Valdivia North American president for Clinique as part of an ongoing restructuring at the firm. The newly created positions, effective Jan. 1, reflect an initiative to strengthen sales in the region, the company said

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011770

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel